Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis.

about

The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd.Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis

P2860

Q48505400-0BE2A662-29A7-4F17-BB85-CA7C87345BBD Q57291166-2B404A7B-3C3B-4208-8433-76D3EC2B443E

P2860

Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis.

Item

http://www.wikidata.org/entity/Q47133089

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Combinations of Respiratory Ch ...... st Mycobacterium tuberculosis.

@en

Combinations of Respiratory Ch ...... st Mycobacterium tuberculosis.

@nl

type

Item

label

Combinations of Respiratory Ch ...... st Mycobacterium tuberculosis.

@en

Combinations of Respiratory Ch ...... st Mycobacterium tuberculosis.

@nl

prefLabel

Combinations of Respiratory Ch ...... st Mycobacterium tuberculosis.

@en

Combinations of Respiratory Ch ...... st Mycobacterium tuberculosis.

@nl

P1476

Combinations of Respiratory Ch ...... st Mycobacterium tuberculosis.

@en

P2093

Bryan J Berube

http://www.w3.org/2001/XMLSchema#string

Tanya Parish

http://www.w3.org/2001/XMLSchema#string

P2860

Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses

Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB

A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis

Diarylquinolines target subunit c of mycobacterial ATP synthase

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis.

Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism.

Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis.

High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.

Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection.

P31

scholarly article

P356

10.1128/AAC.01677-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29061760

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

5740367

http://www.w3.org/2001/XMLSchema#string

Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis.

about

P2860

P2860

Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P577

P698

P921

P932